2023
Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022
Klaassen F, Chitwood M, Cohen T, Pitzer V, Russi M, Swartwood N, Salomon J, Menzies N. Changes in Population Immunity Against Infection and Severe Disease From Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variants in the United States Between December 2021 and November 2022. Clinical Infectious Diseases 2023, 77: 355-361. PMID: 37074868, PMCID: PMC10425195, DOI: 10.1093/cid/ciad210.Peer-Reviewed Original ResearchConceptsSevere diseasePopulation immunityOmicron infectionOmicron variantUS populationSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2SARS-CoV-2 infectionRespiratory syndrome coronavirus 2SARS-CoV-2 Omicron variantRestoration of immunitySyndrome coronavirus 2Bayesian evidence synthesis modelInfection-acquired immunityEvidence synthesis modelSARS-CoV-2Prior immunological exposureCoronavirus 2Additional infectionsImmunological exposureInfectionDiseaseImmunityVaccinationUnited States
2010
Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States
Shaman J, Pitzer VE, Viboud C, Grenfell BT, Lipsitch M. Absolute Humidity and the Seasonal Onset of Influenza in the Continental United States. PLOS Biology 2010, 8: e1000316. PMID: 20186267, PMCID: PMC2826374, DOI: 10.1371/journal.pbio.1000316.Peer-Reviewed Original ResearchConceptsInfluenza-related mortalityInfluenza transmission rateSeasonal influenzaEpidemiological supportInfluenza transmissionInfluenza virusInfluenza transmissibilityPrior weekMortalityInfluenzaUnited StatesPopulation levelOnsetEpidemiological modelAirborne survivalAbsolute humidity levelsDirect modulationFindings